Skip to main content Accessibility help
×
Home

Cerebral Metastases from Malignant Melanoma

  • Ivar M. Mendez (a1) and Rolando F. Del Maestro (a1)

Abstract:

Six hundred and fifty-two patients with histologically proven primary malignant melanoma have been followed by the London Regional Cancer Centre from 1960 to 1985. Neurological signs and symptoms secondary to metastases to the brain developed in fifty-five patients (8.4%). The median age was 49 years; 71% were male and 29% female. Multiple lesions were found in 61% and a single metastasis in 39%. The most common site for the primary lesion was the trunk in males (44%) and the lower limb in females (37%). Six month survival for patients with a single metastasis was 58% if surgical excision was possible and 25% of these patients survived greater than two years. In patients with multiple metastases that received radiotherapy, survival times of greater than six months were found in 12% of the patients. Patients with a single metastasis appear to benefit by being managed by surgical removal of the lesion.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cerebral Metastases from Malignant Melanoma
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cerebral Metastases from Malignant Melanoma
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cerebral Metastases from Malignant Melanoma
      Available formats
      ×

Copyright

Corresponding author

Brain Research Laboratory, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5

References

Hide All
1.Amer, MH, Al-Sarraf, M, Baker, HL. Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival. Cancer 1978; 42: 660668.
2.Beresford, HR. Melanoma of the CNS treatment with corticoste-roids and radiation. Neurology (NY) 1969; 19: 5965.
3.Bullard, DE, Cox, EB, Seigler, HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981; 8: 2630.
4.Budman, DR, Camacho, E, Wittes, RE. The current causes of death in patients with malignant melanoma. Eur J Cancer 1978a; 14: 327330.
5.Leigh, A. Melanoma of the central nervous system. Aust. NZ J Surg 1978; 48: 1416.
6.Stehlin, JS Jr, Hills, WJ, Rufino, C. Disseminated melanoma biologic behaviour and treatment. Arch Surg 1967; 94: 495501.
7.Byrne, TN, Cascino, TL, Posner, JB. Brain metastasis from melanoma. J Neuro-Oncology 1983; 1: 313:317.
8.Bauman, ML, Thomas, PR.Intracranial metastatic malignant melanoma; long term survival following subtotal resection. Southern Med J 1972; 65: 344ߝ346.
9.McCann, WP, Weir, BKA. Long term survival after removal of metastatic malignant melanoma of the brain. J Neurosurg 1968; 29: 483487.
10.Cairncross, SG, Kim, JH, Posner, BJ. Radiation therapy for brain metastases. Ann Neur 1980; 7: 529541.
11.McBride, CM. Diagnosis and management of malignant melanoma: some current approaches and controversies. In Seventh National Conference Proceedings pp 581-585 Philadelphia, J.B. Lippincott Co., 1973.
12.Fell, DA, Leavens, ME, McBride, CM. Surgical versus nonsurgical management of metastatic melanoma of the brain. Neurosurgery 1980; 7: 238242.
13.Hilaries, BS, Raben, M, Calabrese, AS, et al. Value of radiation therapy for distant metastases from malignant melanoma. Cancer 1963; 18: 765773.
14.Moon, JH. Combination chemotherapy of malignant melanoma. Cancer 1970; 25: 468473.
15.Hafstrom, L, Jonsson, PE, Stromblad, LG. Intracranial metastasis of malignant melanoma treated by surgery. Cancer 1980; 46: 20882090.
16.Vieth, RG, Odom, GL. Intracranial metastases and their surgical treatment. J Neurosurg 1975; 23: 375438.
17.McNeil, DP, Leavens, ME. Long term survival with recurrent metastatic intracranial melanoma. J. Neurosurg 1968; 29: 9193.
18.Carella, RJ, Gelber, R, Hendrickson, F, et al. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Cancer 1980; 45: 679683.
19.Rofstad, EK. Radiation biology of malignant melanoma. Acta-Radiol (Oncol), 1986; 25: 110.
20.Rofstad, EK. Growth and radiosensitivity of malignant melanoma multicellular spheroids initiated directly from surgical specimens of tumours in man. Br J Cancer 1986; 54: 569578.
21.Overgaard, J. The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiological study. Int J Radiet Oncol Biol Phys 1986; 12: 867872.
22.Ziegler, JC, Cooper, JS. Brain metastases from malignant melanoma: Conventional vs. high dose per fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 18391842.
23.Richmond, A, Fine, F, Murray, D, et al. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 1986; 86: 295302.
24.Kim, MK, Warren, TC and Kimball, ES. Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. J Biol Chem 1985; 260: 92379243.
25.Ellis, DL, Kafka, SP, Chow, JC, et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987; 317: 15821587.
26.Derynck, R, Goeddel, DV, Ullrich, A, et al. Synthesis of messenger RN As for transforming growth factors a and β and the epidermal growth factor receptor by human tumours. Cancer Res 1987; 47: 707712.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed